Board of Directors' proposals to the Annual General Meeting

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
110
Board of Directors' proposals to the Annual General Meeting to be held on April 4, 2017

Tikkurila Oyj Stock Exchange Release February 9, 2017 at 9:05 a.m. (CET+1)

Board of Directors' proposals to the Annual General Meeting to be held on April 4, 2017

The proposals of the Nomination Board of Tikkurila Oyj to the Annual General Meeting concerning the number, election and remuneration of the members of the Board of Directors have been published on January 25, 2017.

The Annual General Meeting of Tikkurila Oyj will be held on Wednesday April 4, 2017 at 10.00 a.m. in Finlandia Hall, Mannerheimintie 13, Helsinki, Finland. The notice of the Annual General Meeting will be published on March 1, 2017 on Tikkurila Oyj's website and as a stock exchange release. A summary of the notice will be published in Helsingin Sanomat on March 2, 2017.

Resolution on the use of the profit shown on the balance sheet and the payment of dividend.

The Board of Directors proposes to the Annual General Meeting that a dividend of EUR 0,80 per share will be paid for the year ended on December 31, 2016 and that the rest be retained and carried further in the Company's unrestricted equity. The proposed dividend totals approximately EUR 35,3 million, which corresponds to approximately 79% percent of the Group's net profit for 2016. The record date for the payment of the dividend will be April 6, 2017 and the proposed payment date is April 13, 2017.

Resolution on the remuneration of the Auditor

The Board of Directors proposes to the Annual General Meeting, on the recommendation of the Audit Committee, that the Auditor's fees be paid against an invoice approved by the Company.

Election of the Auditor

The Board of Directors proposes to the Annual General Meeting, on the recommendation of the Audit Committee, that KPMG Oy Ab be elected as the Company's auditor for the term that ends at the conclusion of the Annual General Meeting following the appointment. KPMG Oy Ab has informed that APA Toni Aaltonen will act as the principal auditor.

Authorizing the Board of Directors to decide on the repurchase of the Company's own shares

The Board of Directors proposes that the Annual General Meeting authorize the Board of Directors to decide upon the repurchase of a maximum of 4,400,000 Company's own shares with assets pertaining to the company's unrestricted equity in one or more tranches. The proposed maximum amount of the authorization corresponds to approximately 10 percent of all the shares in the Company.

The authorization for repurchases of Company's own shares is proposed to be carried out at the market price of the share on Nasdaq Helsinki Ltd or in other marketplace the rules of which allow companies to trade with their own shares. The authorization entitles the Board of Directors to repurchase the shares in another proportion than that of the shares held by the current shareholders (directed repurchase). In repurchasing of the Company's own shares, the Company may enter into derivative, stock lending or other arrangements customary in capital market practice within the limits set by law and other regulations. In repurchases, the Company will follow the rules and guidelines regarding, among other factors, the determination of the repurchase price, settlement and disclosure of trades, of the marketplace in which the repurchase is carried out.

The consideration payable for the repurchase of the shares shall be based on the market price of the Company's share on the securities market. The minimum consideration of the repurchase of the Company's own shares is the lowest market price of the share quoted during the authorization period and, correspondingly, the maximum price is the highest market price of the share quoted during the authorization period.

The shares may be repurchased to be used for financing or implementing possible mergers and acquisitions, developing the Company's equity structure, improving the liquidity of the Company's shares or to be used for the payment of the annual fees payable to the members of the Board of Directors or for implementing the share-based incentive programs of the Company. For the aforementioned purposes, the Company may retain, transfer further or cancel the shares. The Board of Directors would decide upon other terms related to repurchase of shares.

The repurchase authorization would be valid until the end of the next Annual General Meeting, however, no longer than until June 30, 2018.

This authorization would cancel the repurchase authorization granted by the Annual General Meeting to the Board of Directors on April 6, 2016.

Authorizing the Board of Directors to decide on the issuance of shares

The Board of Directors proposes that the Annual General Meeting authorize the Board of Directors to decide to transfer the Company's own shares held by the Company or to issue new shares in one or more tranches limited to a maximum of 4,400,000 shares. The proposed maximum aggregate amount of the authorization corresponds to approximately 10 percent of all the shares in the Company.

The Company's own shares held by the Company may be transferred and the new shares may be issued either against payment or without payment. The new shares may be issued and the Company's own shares held by the Company may be transferred to the Company's shareholders in proportion to their current shareholdings in the Company or in deviation from the shareholders' pre-emptive right through a directed share issue, if the Company has a weighty financial reason to do so, such as financing or implementing mergers and acquisitions, developing the Company's equity structure, improving the liquidity of the Company's shares, settling the payment of the annual fees payable to the members of the Board of Directors or implementing the share-based incentive programs of the company. Upon the issuance of the new shares, the subscription price of the new shares shall be recorded to the invested unrestricted equity reserves. In case of a transfer of the Company's own shares, the price payable for the shares shall be recorded to the invested unrestricted equity reserves.

The Board of Directors would decide upon other terms and conditions related to the share issues. The authorization would be valid until the end of the next Annual General Meeting, however, no longer than until June 30, 2018.

This authorization would cancel the share issue authorization granted by the Annual General Meeting to the Board of Directors on April 6, 2016.

Tikkurila Oyj Erkki Järvinen, President and CEO

For further information, please contact: Antti Kiuru, Tikkurila Oyj, Group Vice President, Legal, mobile +358 400 686 488, antti.kiuru@tikkurila.com

Tikkurila is the leading paints and coatings professional in the Nordic region and Russia. With our roots in Finland, we now operate in 14 countries. Our high-quality products and extensive services ensure the best possible user experience in the market. Sustainable beauty since 1862.

www.tikkurilagroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Prix Galien Nominations Spotlight Global Healing

Updated Category News Views 62

Beyond the Hype: Innovating for Healthier Tomorrows Kicking off in Stockholm on December 1st, the 2026 Prix Galien Bridges Awards isn't just some schmooze-fest; it's a hard-hitting showcase of where true innovation can propel healthcare. Over at the Karolinska Institutet, the Galien Foundation is drawing powerhouses from across the Nordics+ region and showcasing...

Continue Reading
Cell Counting Market Growth: USD 17.71 Billion by 2031

Updated Category News Views 199

The Cell Counting Surge: Money Talks in Science You can't deny it when the numbers speak—a jump from USD 12.39 billion to USD 17.71 billion by 2031 in the cell counting market means something ain't business as usual. That's a robust 7.40% CAGR folks; it's a field being bombarded with innovation. The spark? Automated and advanced cell analysis technology taking the...

Continue Reading
TransDigm Surges Ahead with Strong Q4 and FY Results

Updated Category News Views 87

TransDigm's Impressive Performance in Fiscal 2026 Here's a company that's really kicking it up a notch—TransDigm Group (NYSE:TDG) just reported some solid fourth-quarter numbers that scream growth. Net sales soared to $2,988 million, marking a 23% hike from last year's fourth quarter of $2,437 million. That's a cool $551 million leap, quite the party for shareholders....

Continue Reading
Braemar's $358 Million Refinance: A Strategic Shift

Updated Category News Views 67

Reworking the Debt Load: Braemar's New Move Most days, when a company decides to tinker with its debt, it's like watching paint dry for investors. But with Braemar Hotels & Resorts (NYSE: BHR) announcing a $358 million refinancing package, they're bringing a fresh breath of air to the table. Lemme walk you through why this matters beyond the glossy façade of luxury hotel...

Continue Reading
PC Richard & Son Offers Big Black Friday Savings

Updated Category News Views 96

Holiday Prep Kicks Into High Gear As November ticks on, folks are diving headfirst into the frenzy of holiday planning and spending. What better time for a salvo of sales from P.C. Richard & Son? The appliance stalwart is throwing down the gauntlet with hefty discounts and some intriguing offers on TVs, mattresses, and more. With Black Friday looming, the savvy shopper...

Continue Reading
Fake Profiles Dominate Daters' Trust Issues Today

Updated Category News Views 211

Trust Erosion in the Digital Dating Arena When it comes to modern dating, we're not talking hearts and flowers anymore; it's more like an elaborate game of detective work. A recent survey from Stud or Dud highlights the harsh reality that blind trust in digital dating profiles is about as outdated as sending a singing telegram. Almost half of the respondents pinned fake...

Continue Reading
Hi Peach Layne Rides Trend with New Hair Repair Oil

Updated Category News Views 45

Diving into Beauty Economics with Walmart Now here's a story that ticks every box in the bargain bin playbook—Hi Peach Layne's latest move into the haircare aisle. They're launching a Hair Repair Oil loaded with claims that shout 'value!' loud enough to echo down a Walmart aisle. With a price point of $9.97, it's sliding right into Walmart's "Beauty Finds Under $10"...

Continue Reading
Thesis Elements Expands Portfolio with Mappify Buy

Updated Category News Views 32

Mappify Acquisition: A Smooth Move for Higher Ed Picture a college student trying to juggle classes, work, and life like it's a circus act. That's not too far off from reality, and it's where Thesis America and its new acquisition, Mappify, come into play. By scooping up Mappify, Thesis aims to untangle this scheduling chaos for students across the board. From Data to...

Continue Reading
The DOG CATCHER: A New Spin on Pet Waste Cleanup

Updated Category News Views 43

Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...

Continue Reading
Envista's $430M Senior Notes: A Market Move Decoded

Updated Category News Views 114

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Asieris Pharmaceuticals Reveals Exciting Cevira Study Insights

Updated Category News Views 107

Asieris Pharmaceuticals dropped some heavy news back in 2024 about its Phase III study for Cevira (APL-1702), a drug aiming to tackle cervical High-Grade Squamous Intraepithelial Lesion (HSIL). This ain’t just another clinical trial; it’s a serious play against HPV, and the desks are buzzing with implications. So, what’s the deal? Traders were tuning in hard after...

Continue Reading
Synchronoss Technologies Schedules Q1 2025 Earnings Call

Updated Category News Views 132

Synchronoss Technologies Schedules First Quarter Earnings Call BRIDGEWATER, N.J. — Synchronoss Technologies Inc. (Nasdaq: SNCR), a prominent innovator in Personal Cloud platforms, is gearing up for its upcoming conference call. Details of the Earnings Call This important event is set to take place on a Tuesday in May at 4:30 p.m. Eastern time, following the company’s...

Continue Reading
Perma-Fix Environmental Services Conference Call Scheduled

Updated Category News Views 126

Perma-Fix Announces Upcoming Business Update Conference Call Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) has exciting plans for its investors. The Company has announced that it will host a business update conference call, set for 11:00 AM Eastern Time on an upcoming Wednesday. This event is significant as it offers an opportunity for investors and interested...

Continue Reading
Atos Group's 2025 Liquidity Position: Insights and Updates

Updated Category News Views 549

Understanding Atos Group's 2025 Liquid Position Atos Group recently shared its anticipated liquidity position for the first half of 2025, providing crucial insights into its financial health. As a major player in digital transformation, the company aims to maintain transparency in its financial reporting, particularly to its stakeholders. Liquidity Insights and Financial...

Continue Reading
Investigation into Shareholder Rights for BCOV, ENLC, CCRN

Updated Category News Views 173

Investigation into Shareholder Rights Halper Sadeh LLC, a prominent law firm focused on investor rights, is engaging in a comprehensive investigation regarding several companies regarding potential violations of federal securities laws and fiduciary duties to shareholders. Brightcove Inc. and Its Recent Sale Brightcove Inc. (NASDAQ: BCOV) has announced a sale to Bending...

Continue Reading